This work is licensed under a Creative Commons Attribution 4.0 International License.
B1-L-2
General Information
DRACP ID DRACP05882
Peptide Name B1-L-2
Sequence VKRFⓍKFFⓍKLKKLV
Sequence Length 15
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Cancer targeted peptides Stapled Peptides Membrane-targeted
Activity Information
| Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
|---|---|---|---|---|---|---|
| Huh-7 | Adult hepatocellular carcinoma; Adult hepatocellular carcinoma | Carcinoma | IC50=6.18±0.63 μM | CCK-8 assay | 48 h | 1 |
| MCF-7 | Invasive breast carcinoma of no special type | Carcinoma | IC50=6.591±0.42 μM | CCK-8 assay | 48 h | 1 |
| U87 | Glioblastoma | Blastoma | IC50=8.86±1.43 μM | CCK-8 assay | 48 h | 1 |
Hemolytic Activity HC50>80 μM
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity 35.5
Linear/Cyclic Cyclic (Stapled)
Disulfide/Other Bond Stapled: Ⓧ are cross-linked by hydrocarbon stapling
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification Ⓧ=(S)-2-(4-pentenyl) alanine amino acid
Chiral L
Physicochemical Information
Formula C85H137N21O12
Absent amino acids ACDEGHIMNPQSTWY
Common amino acids K
Mass 189504
Pl 12.05
Basic residues 6
Acidic residues 0
Hydrophobic residues 7
Net charge 6
Boman Index -1581
Hydrophobicity 2.67
Aliphatic Index 90.67
Half Life
/
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 35464194
Title Design, Synthesis, and Antitumor Activity Study of All-Hydrocarbon-Stapled B1-Leu Peptides
Year 2022
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
This work is licensed under a Creative Commons Attribution 4.0 International License.